Back to the Mid-American Newsfeed

Kent State wide receiver Antwan Dixon begins chemotherapy treatment for aplastic anemia

Antwan Dixon was poised for a breakout in 2016 after a true freshman campaign that saw him lead the Flashes in receiving yards (355) place second in receptions (26) and had 126 yards on the ground, scoring one receiving touchdown.

A blood disorder, known as aplastic anemia, sidelined him for his entire true sophomore campaign and also put his life in danger. Dixon had to go back to his native Florida to go through treatments.

Aplastic anemia is a particularly impactful disease, destroying blood-creating cells in the bone marrow, including red blood cells, platlets and white blood cells.